Medigus
Omer Industrial Park
Building 7A<br>P.O. Box 3030
Omer
3030
Tel: 972-8-6466-880
Fax: 972-8-6466-770
Website: http://www.medigus.com/
Email: info@medigus.com
67 articles about Medigus
-
Medigus Board Files a Motion to Approve an Up to $1.6 Million Dividend Distribution
9/8/2022
Medigus Ltd. announced that the Company filed a motion with the Tel Aviv District Court Economic Department for approval of a dividend distribution up to of $1.6 million.
-
Medigus: Polyrizon Signed an Agreement with Nurexone for Intranasal Administration of Cutting - Edge Therapy for Spinal Cord Injuries
7/18/2022
Medigus Ltd. announced today that Polyrizon Ltd. ("Polyrizon"), an Israeli biotech company that specializes in innovative intranasal products in which Medigus owns 37.03%, signed a binding Collaboration Agreement with NurExone Biologic Inc.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 26, 2020.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 1, 2020.
-
Medigus to Participate in a European Consortium for the Development of a Fluorescent Colonoscope Intended to Improve Detection of Colorectal Cancer
1/23/2019
Medigus Ltd. announced today that it has filed an application under the framework of a consortium for a European grant for the development of a fluorescent colonoscope from Horizon 2020 fund.
-
Medigus Announces First MUSE Procedure for the Treatment of GERD Performed in Israel at Shaare-Zedek Medical Center
12/27/2017
The MUSE system is a single-use flexible transoral stapler that merges the latest advancement in microvisual, ultrasonic and surgical stapling.
-
Medigus Announces Distribution Agreement With Micro-Tech Europe for the MUSE System in Germany
12/4/2017
Under the terms of the agreement, Micro-Tech Europe will be the exclusive distributor for the MUSE System in Germany.
-
Medigus Announces Third Quarter 2017 Financial Results
11/27/2017
Medigus today announced financial results for the third quarter ended September 30, 2017.
-
Medigus Announces Second Quarter 2017 Financial Results
9/20/2017
-
Medigus Broadens Availability Of MUSE Through Distribution Agreement With ADMEDICS AG In Switzerland And Liechtenstein
7/26/2017
-
Medigus Expands Global Commercial Availability Of MUSE Through Distribution Agreement With Izasa Hospital, S.L.U. In Spain
7/19/2017
-
Medigus And Golden Grand Expand Distribution Arrangement In China For $27M Of MUSE Systems
7/18/2017
-
Medigus Announces First Quarter 2017 Financial Results
5/31/2017
-
Medigus Announces Japanese And European Patents For micro ScoutCam Microvisual Technology
5/16/2017
-
Medigus Presents New Data Demonstrating The MUSE System Improves GERD Symptoms And Reduces Proton Pump Inhibitor Reliance
5/10/2017
-
Medigus Release: New Data On The MUSE System To Be Presented During Digestive Disease Week (DDW) 2017
5/4/2017
-
Medigus Regains Compliance With The Nasdaq Listing Requirements
4/4/2017
-
Medigus Announces Availability Of Annual Report on Form 20-F
4/3/2017
-
Medigus Announces $7.5 Million Public Offering
3/24/2017
-
Medigus Release: First MUSE Procedures For Treatment Of GERD Performed In Switzerland
3/15/2017